Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with (99m)Tc

Bioconjugate Chemistry

Volumn 8, Issue 2, 1997, Pages 155-160

  Barrett, John A ^a   Crocker, Andrew C ^a   Damphousse, David J ^a   Heminway, Stuart J ^a   Liu, Shuang ^a   Edwards, D Scott ^a   Lazewatsky, Joel L ^a   Kagan, Mikhail ^a   Mazaika, Theresa J ^a   Carroll, Timothy R ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; GLYCOPROTEINS; NUCLEAR MEDICINE; PHOSPHORUS COMPOUNDS; PROTEINS; VISUALIZATION;

ARTERIOVENOUS SHUNT; BIOLOGICAL EVALUATION; CO-LIGANDS; COMPLEX 1; DEEP VEIN THROMBOSIS; IMAGING AGENT; IMAGING MODELING; RECEPTOR ANTAGONISTS; TRIPHENYL PHOSPHINES; WATERSOLUBLE;

BLOOD VESSELS;

ANIMALIA; CANIS FAMILIARIS; THROMBUS;

EID: 0031105934     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970001p     Document Type: Article

References (16)

1. 99mTc. Bioconjugate Chem. 8, 146-154.
2. Barrett, J. A., Heminway, S. J., Damphousse, D. J., Thomas, J. R., Looby, R. J., Edwards, D. S., Harris, T. D., Rajopadhye, M., Liu, S., and Carroll, T. R. (1994) Platelet GP IIb/IIIa antagonists in the canine arteriovenous shunt: potential thrombus imaging agents. J. Nucl. Med. 35, 52P (Abstract 202).
3. Harris, T. D., Rajopadhye, M., Damphousse, P. R., Glowacka, D., Yu, K., Bourque, J., Barrett, J. A., Damphousse, D. J., Heminway, S. J., Lazewatsky, J., Mazaika, T., and Carroll, T. R. (1996) Tc-99m-labeled fibrinogen receptor antagonists: Design and synthesis of cyclic RGD peptides for the detection of thrombi. Bioorg. Med. Chem. Lett. 6, 1741-1746.
4. Barrett, J. A., Bresnick, M., Crocker, A., Damphousse, D. J., Hampson, J. R., Heminway, S. J., Mazaika, T. J., Kagan, M., Lazewatsky, J., Edwards, D. S., Liu, S., Harris, T. D., Rajopadhye, M., and Carroll, T. R. (1995) RP-431: a potential thrombus imaging agent. J. Nucl. Med. 36, 16P (Abstract 55).
5. 99mTc using aminocarboxylates as coligands. Bioconjugate Chem. 7, 63-71.
6. 99mTc by the preformed chelate approach. Bioconjugate Chem. 7, 196-202.
7. 99mTc-chelator-peptide conjugates. Bioconjugate Chem. 7, 203-208.
8. Knight, L. C. (1990) Radiopharmaceuticals for thrombus detection. Semin. Nucl. Med. 20, 52-67.
9. Fuster, V., Stein, B., Badimon, L., and Chesebro, J. (1988) Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction. J. Am. Col. Cardiol. 12, 78A-84A.
10. Plow, E. F., Marguerie, G., and Ginsberg, M. (1987) Fibrinogen, fibrinogen receptors and the peptides that inhibit these interactions. Biochem. Pharmacol. 36, 4035-4041.
11. Shattil, S. J., Hoxie, J. A., Cunningham, M., and Brass, L. F. (1985) Changes in the platelet membrane glycoprotein IIb/ IIIa complex during platelet activation. J. Biol. Chem. 260, 11107-11110.
12. Thakur, M. L., Welch, M. J., Joist, J. H., and Coleman, R. E. (1976) In-111 labeled platlets: studies on preparation and evaluation of in vitro and in vivo function. Thrombus Res. 9, 345-357.
13. Haskel, E., Adams, S., Feigen, L., Saffitz, J., Gorczynski, R., Sobel, D., and Abendschein, D. (1989) Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/ IIIa receptors. Circulation 80, 1775-1782.
14. Oster, Z., Srivastava, S., Som, P., Meinken, G., Scudder, L., Yamamoto, K., Atkins, H., Brill, A., and Coller, B. (1985) Thrombus radioimmunoscintigraphy: An approach using monoclonal antiplatelet antibody. Proc. Natl. Acad. Sci. U.S.A. 82, 3465-3468.
15. Knight, L., Maurer, A., and Romano, J. (1996) Comparison of iodine-123-disintegrins for imaging thrombi and emboli in a canine model. J. Nucl. Med. 37, 476-482.
16. Muto, P., Lastoria, S., Varrella, P., Vergara, E., Salvatore, M., Morgano, G., Lister-James, J., Bernardy, J., Dean, R., Wencker, D., and Borer, J. (1995) Detecting deep venous thrombosis with technetium-99m-labeled synthetic peptide P280. J. Nucl. Med. 36, 1384-1391.